News & Press Releases
Filter by:
Three Mintz Attorneys Named 2025 BTI Client Service All-Stars
August 29, 2025
Mintz Members Daniel Bleck, Poonam Patidar, and Vanessa Yen have been named to BTI Consulting Group’s 2025 Client Service All-Star list. This recognition celebrates attorneys who consistently deliver the highest tier of client service.
Mintz Intellectual Property Chair Michael Renaud has been named a Go-To Lawyer by Massachusetts Lawyers Weekly in its 2025 Intellectual Property Law edition. This award recognizes senior attorneys with proven legal acumen, successful results, strong peer referrals, and a reputation for innovative thinking.
173 Mintz Attorneys Across 53 Practice Areas Recognized by The Best Lawyers in America 2026
August 28, 2025
173 Mintz attorneys across 53 practice areas have been recognized by Best Lawyers® in the 2026 edition of The Best Lawyers in America©. Five Mintz attorneys received 2026 “Lawyer of the Year” awards, and 61 firm attorneys were included in the 2026 edition of Best Lawyers: Ones to Watch.
How Bankruptcy Law Caps Landlords' Rejected Lease Claims
August 28, 2025
Law360 published an article written by Associate Dormie Ko, Member Geoffrey Smith, and Of Counsel Timothy McKeon about how landlords often find themselves in disputes with debtor-tenants over damages resulting from companies using the bankruptcy process to reject unwanted leases. Given the significant increase in corporate bankruptcy filings in recent years, the authors outline what landlords should consider if their leases are rejected in bankruptcy.
As Congress Preps PAMA Reform Bill, Legislators Ask CMS to Delay Law's Implementation
August 28, 2025
Health Law Practice Chair and Health Care Enforcement Defense Practice Co-chair Karen Lovitch shared insights with 360Dx on recent letters sent by legislators to the Centers for Medicare and Medicaid Services (CMS), which request a delay in upcoming price cuts and reporting requirements related to the Protecting Access to Medicare Act (PAMA). Karen notes that the requests appear to fall within CMS's regulatory authority and align with past congressional actions aimed at maintaining stability in lab reimbursement policy.
